Skip to main content
. 2016 Jun 16;11(6):e0157334. doi: 10.1371/journal.pone.0157334

Fig 3. In silico interaction of TF101 and AI-2 with the LsrB receptor.

Fig 3

In silico analyses predicted possible protein ligand interaction of TF101 and the LsrB receptor, indicating that TF101 might act as a competitive antagonist for the AI-2 receptor.